MedPath

Immuno-nutrition Supplementation in Haemodialysis

Not Applicable
Completed
Conditions
Chronic Kidney Disease Requiring Chronic Dialysis
Interventions
Dietary Supplement: Immuno-nutrition supplement
Registration Number
NCT05700851
Lead Sponsor
University of Nottingham
Brief Summary

The purpose of this pilot study is to test if an "immuno-nutrition" supplement can decrease inflammation in people on haemodialysis. This immuno-nutrition supplement is high in calories and protein like other common nutritional supplements, but also contains a unique combination of ingredients that have been shown to reduce inflammation (a problem which is caused by the body's defence \[immune\] system communicating that something is wrong) and improve the immune system in people with cancer. The research team hopes that this small study will help with gaining a good understanding of the effect of immuno-nutrition on inflammation in people on haemodialysis, which will guide and allow the research team to do a larger research study in the future.

Detailed Description

Participants will be asked to take one sachet of the immuno-nutrition supplement each day for 6 weeks. The renal dietitian on the research team will provide participants with detailed oral advice on how and when to take the immuno-nutrition supplement.

Participants will need to complete 3-day food diaries at the beginning, mid-way point and end of the study.

The research team will measure weight, height, handgrip strength (a measure of muscle strength), body's composition of fat and muscle using a specialist scale, and skin autofluorescence levels (a measure of toxins called advanced glycation end-products).

The research team will collect the results of routine blood tests. The research team will also collect and store blood samples taken before and after a haemodialysis session to measure some molecules that indicate inflammation.

All of these measurements and samples will be taken at the start of the study, and after 6 weeks of taking the immuno-nutrition supplement.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • CRP level >5.0 mg/L.
  • At least three haemodialysis sessions per week for ≥3 hours using a biocompatible dialyser.
  • Able to give informed consent.
Exclusion Criteria
  • Treatment with drugs that cause immunosuppression.
  • Non-English speakers or those with special communication needs.
  • Pregnancy, breast feeding or intending pregnancy.
  • Expected survival <6 months.
  • Hospitalisation at the time of screening.
  • Known intolerance or allergy to ONS (or isolated ingredients).
  • Pre-dialysis serum potassium >5.0 mmol/L.
  • Unable to provide informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Immuno-nutritionImmuno-nutrition supplementParticipants will be advised to take daily one sachet (74 g) of the immuno-nutrition supplement (Oral Impact®, Nestle) dissolved in 125 ml of water and will be followed-up for 6 weeks. Participants will receive individualised (to patient needs and food preferences) dietetic advice formulated and delivered by an experienced renal dietitian under an honorary NHS research contract, who is a member of the research team and will be supervised by an NHS renal dietitian, aiming to achieve estimated nutritional requirements for people on haemodialysis (i.e., energy: 30-35 kcal/kg/day, and protein intake: 1.0-1.2 g/kg/day). Each dietetic advice provided to participants will also be reviewed by the NHS clinical renal dietitians who are members of the participants' usual clinical care team.
Primary Outcome Measures
NameTimeMethod
C Reactive Protein - Marker of Systemic Inflammation6 weeks

C reactive protein levels in mg/L using a high-sensitive laboratory test

Interleukin-6 - Marker of Systemic Inflammation6 weeks

Interleukin-6 levels in pg/ml using enzyme-linked immunosorbent assay

Interleukin-8 - Marker of Systemic Inflammation6 weeks

Interleukin-8 levels in pg/ml using enzyme-linked immunosorbent assay

Secondary Outcome Measures
NameTimeMethod
Skeletal Muscle Mass6 weeks

Skeletal muscle mass in kg assessed with the InBody 770 Multi-Frequency Bioimpedance Analysis equipment.

Energy Intake6 weeks

Energy intake in kcal/kg of body weight/day assessed with 3-day food diaries and analysed using the diet software Nutritics

Protein Intake6 weeks

Protein intake in g/kg of body weight/day assessed with 3-day food diaries and analysed using the diet software Nutritics

Handgrip Strength - a Measure of Muscle Strength6 weeks

Handgrip strength in kg measured with the Takei 5401 handgrip digital dynamometer

Trial Locations

Locations (1)

Department of Renal Medicine, Royal Derby Hospital

🇬🇧

Derby, Derbyshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath